pre-miRNA Information
pre-miRNA hsa-mir-6132   
Genomic Coordinates chr7: 117020211 - 117020319
Description Homo sapiens miR-6132 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-6132
Sequence 21| AGCAGGGCUGGGGAUUGCA |39
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1272646274 4 dbSNP
rs1211969145 8 dbSNP
rs1310278496 11 dbSNP
rs1044115534 13 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol LY6E   
Synonyms RIG-E, RIGE, SCA-2, SCA2, TSA-1
Description lymphocyte antigen 6 family member E
Transcript NM_001127213   
Other Transcripts NM_002346   
Expression
Putative miRNA Targets on LY6E
3'UTR of LY6E
(miRNA target sites are highlighted)
>LY6E|NM_001127213|3'UTR
   1 CCGCCCAGACCCTGTCCCCCGATCCCCCAGCTCAGGAAGGAAAGCCCAGCCCTTTCTGGATCCCACAGTGTATGGGAGCC
  81 CCTGACTCCTCACGTGCCTGATCTGTGCCCTTGGTCCCAGGTCAGGCCCACCCCCTGCACCTCCACCTGCCCCAGCCCCT
 161 GCCTCTGCCCCAAGTGGGGCCAGCTGCCCTCACTTCTGGGGTGGATGATGTGACCTTCCTTGGGGGACTGCGGAAGGGAC
 241 GAGGGTTCCCTGGAGTCTTACGGTCCAACATCAGGACCAAGTCCCATGGACATGCTGACAGGGTCCCCAGGGAGACCGTG
 321 TCAGTAGGGATGTGTGCCTGGCTGTGTACGTGGGTGTGCAGTGCACGTGAGAGCACGTGGCGGCTTCTGGGGGCCATGTT
 401 TGGGGAGGGAGGTGTGCCAGCAGCCTGGAGAGCCTCAGTCCCTGTAGCCCCCTGCCCTGGCACAGCTGCATGCACTTCAA
 481 GGGCAGCCTTTGGGGGTTGGGGTTTCTGCCACTTCCGGGTCTAGGCCCTGCCCCAAATCCAGCCAGTCCTGCCCCAGCCC
 561 ACCCCCACATTGGAGCCCTCCTGCTGCTTTGGTGCCTCAAATAAATACAGATGTCCCCCAGAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' acgUUAGG--GGUCGGGACGa 5'
             |||||  ||||:||||| 
Target 5' ccaAATCCAGCCAGTCCTGCc 3'
533 - 553 154.00 -22.10
2
miRNA  3' acGUUAGGGGUCGGGACGa 5'
            |:: :|: :||||||| 
Target 5' tcCGGGTCTAGGCCCTGCc 3'
514 - 532 149.00 -17.70
3
miRNA  3' acGUUAGGGGUCGGGACga 5'
            :|: |||| ||||||  
Target 5' tgTAGCCCCCTGCCCTGgc 3'
443 - 461 141.00 -24.60
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31956571 3 COSMIC
COSN26983276 12 COSMIC
COSN19507130 21 COSMIC
COSN30500129 25 COSMIC
COSN30452825 48 COSMIC
COSN30454653 63 COSMIC
COSN30512017 65 COSMIC
COSN8575662 109 COSMIC
COSN30527042 147 COSMIC
COSN21882999 249 COSMIC
COSN31960075 394 COSMIC
COSN28663396 518 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1393064226 2 dbSNP
rs774074657 3 dbSNP
rs188567016 4 dbSNP
rs1355624751 6 dbSNP
rs771734245 7 dbSNP
rs1283532866 10 dbSNP
rs1315041225 15 dbSNP
rs773506979 17 dbSNP
rs761025577 21 dbSNP
rs751822701 22 dbSNP
rs900668174 24 dbSNP
rs777067942 25 dbSNP
rs1240232739 28 dbSNP
rs780786588 29 dbSNP
rs1158342383 31 dbSNP
rs1406514565 32 dbSNP
rs1416657379 35 dbSNP
rs374870407 37 dbSNP
rs1406196456 43 dbSNP
rs745674413 48 dbSNP
rs1199268091 58 dbSNP
rs1319919458 67 dbSNP
rs988805298 70 dbSNP
rs1293288568 77 dbSNP
rs998200100 78 dbSNP
rs1367996338 90 dbSNP
rs1276292947 94 dbSNP
rs192838481 95 dbSNP
rs1242365024 98 dbSNP
rs537237172 101 dbSNP
rs1039648872 104 dbSNP
rs1353291469 104 dbSNP
rs1170311325 108 dbSNP
rs1415442472 110 dbSNP
rs1427671850 116 dbSNP
rs886455159 119 dbSNP
rs1459926300 121 dbSNP
rs900653219 122 dbSNP
rs1238731211 127 dbSNP
rs932416342 129 dbSNP
rs1180602113 132 dbSNP
rs1419704405 142 dbSNP
rs1048185054 143 dbSNP
rs1362250554 145 dbSNP
rs1312614277 147 dbSNP
rs113719829 157 dbSNP
rs1231716125 159 dbSNP
rs963394544 160 dbSNP
rs1173521261 165 dbSNP
rs1448392791 177 dbSNP
rs185330105 179 dbSNP
rs1370496276 180 dbSNP
rs888170980 185 dbSNP
rs1298153841 190 dbSNP
rs188373137 199 dbSNP
rs1361332873 209 dbSNP
rs1172170414 216 dbSNP
rs1434428933 221 dbSNP
rs4464948 230 dbSNP
rs1417449650 231 dbSNP
rs1249886033 232 dbSNP
rs554215687 233 dbSNP
rs1483538118 238 dbSNP
rs1014171566 242 dbSNP
rs11547124 262 dbSNP
rs917820304 263 dbSNP
rs969853093 264 dbSNP
rs4478552 265 dbSNP
rs978536398 273 dbSNP
rs1240715956 287 dbSNP
rs1233610499 288 dbSNP
rs1262129158 290 dbSNP
rs1314675911 291 dbSNP
rs1321082186 294 dbSNP
rs1200339020 310 dbSNP
rs1396041628 312 dbSNP
rs966372074 318 dbSNP
rs139919223 319 dbSNP
rs956114177 326 dbSNP
rs1176672995 330 dbSNP
rs1361541659 334 dbSNP
rs1300338554 335 dbSNP
rs1248591663 337 dbSNP
rs1434983441 340 dbSNP
rs1363371364 346 dbSNP
rs1165583897 347 dbSNP
rs777709631 350 dbSNP
rs1419976031 351 dbSNP
rs1185670152 365 dbSNP
rs555035621 367 dbSNP
rs749528517 368 dbSNP
rs1206597904 369 dbSNP
rs770998009 377 dbSNP
rs974977345 378 dbSNP
rs376994588 382 dbSNP
rs922148579 383 dbSNP
rs922121784 384 dbSNP
rs933474274 388 dbSNP
rs1052464322 390 dbSNP
rs930814511 399 dbSNP
rs886653005 402 dbSNP
rs1298188070 411 dbSNP
rs1049217540 424 dbSNP
rs1802886 432 dbSNP
rs909642958 441 dbSNP
rs1392180516 443 dbSNP
rs576592915 444 dbSNP
rs939780698 445 dbSNP
rs1282194884 450 dbSNP
rs1392348377 464 dbSNP
rs1004845844 469 dbSNP
rs370125043 480 dbSNP
rs543973681 485 dbSNP
rs879270452 495 dbSNP
rs1226002811 497 dbSNP
rs1260646692 500 dbSNP
rs1210036269 502 dbSNP
rs1014616365 503 dbSNP
rs1044304437 505 dbSNP
rs1131075 507 dbSNP
rs565308459 516 dbSNP
rs905764619 517 dbSNP
rs532675568 518 dbSNP
rs1306841972 520 dbSNP
rs1131088 522 dbSNP
rs541280024 525 dbSNP
rs1267161520 530 dbSNP
rs980376608 539 dbSNP
rs1326179906 541 dbSNP
rs956357841 543 dbSNP
rs1443358158 545 dbSNP
rs1368952622 552 dbSNP
rs1489476872 555 dbSNP
rs1325307225 565 dbSNP
rs1466156648 567 dbSNP
rs1169537941 568 dbSNP
rs1460314078 569 dbSNP
rs1372269919 571 dbSNP
rs1199203003 572 dbSNP
rs1010302287 578 dbSNP
rs1223365357 581 dbSNP
rs558971110 589 dbSNP
rs966082735 592 dbSNP
rs1192487406 593 dbSNP
rs1457785853 601 dbSNP
rs1275765778 609 dbSNP
rs974717190 616 dbSNP
rs544277643 617 dbSNP
rs760503365 621 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 4061.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine ...

- Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' acguuaggggucGGGACGa 5'
                      |||||| 
Target 5' ---------accCCCUGCa 3'
1 - 10
Article - Memczak S; Jens M; Elefsinioti A; Torti F; et al.
- Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' acguuaggggucGGGACGa 5'
                      |||||| 
Target 5' ------cccaccCCCUGCa 3'
1 - 13
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1065669
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / 4-thiouridine, ML_MM_8
Location of target site ENST00000517503.1 | 3UTR | ACCCCCUGCACCUCCACCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000517503.1 | 3UTR | CCCACCCCCUGCACCUCCACCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
82 hsa-miR-6132 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT067294 NECAP1 NECAP endocytosis associated 1 2 10
MIRT100110 ABT1 activator of basal transcription 1 2 8
MIRT358583 CANX calnexin 2 2
MIRT445247 SEMA5A semaphorin 5A 2 2
MIRT445764 CCND3 cyclin D3 2 2
MIRT452388 LY6E lymphocyte antigen 6 family member E 2 4
MIRT452829 FAM131B family with sequence similarity 131 member B 2 2
MIRT453450 GLG1 golgi glycoprotein 1 2 2
MIRT455435 ID3 inhibitor of DNA binding 3, HLH protein 2 2
MIRT460629 IGFBP4 insulin like growth factor binding protein 4 2 2
MIRT461607 DPH2 DPH2 homolog 2 2
MIRT461989 PACSIN1 protein kinase C and casein kinase substrate in neurons 1 2 2
MIRT464258 VCL vinculin 2 2
MIRT465713 TNFAIP1 TNF alpha induced protein 1 2 2
MIRT466475 TECPR2 tectonin beta-propeller repeat containing 2 2 7
MIRT467119 SRGAP1 SLIT-ROBO Rho GTPase activating protein 1 2 4
MIRT468299 SFT2D2 SFT2 domain containing 2 2 2
MIRT469696 RAB5B RAB5B, member RAS oncogene family 2 8
MIRT469904 PTRF caveolae associated protein 1 2 2
MIRT470015 PTPLB 3-hydroxyacyl-CoA dehydratase 2 1 1
MIRT471385 PDPR pyruvate dehydrogenase phosphatase regulatory subunit 2 2
MIRT471409 PDP2 pyruvate dehyrogenase phosphatase catalytic subunit 2 2 2
MIRT471719 OTUB1 OTU deubiquitinase, ubiquitin aldehyde binding 1 2 2
MIRT473608 MARK2 microtubule affinity regulating kinase 2 2 2
MIRT476328 GLTSCR1L BRD4 interacting chromatin remodeling complex associated protein like 2 2
MIRT479448 CDK6 cyclin dependent kinase 6 2 2
MIRT482032 AMER1 APC membrane recruitment protein 1 2 2
MIRT482360 AGO2 argonaute 2, RISC catalytic component 2 2
MIRT484661 HOXD3 homeobox D3 2 4
MIRT486828 NDOR1 NADPH dependent diflavin oxidoreductase 1 2 2
MIRT487069 CLASP1 cytoplasmic linker associated protein 1 2 4
MIRT487196 NFASC neurofascin 2 4
MIRT487448 TFAP2B transcription factor AP-2 beta 2 4
MIRT487517 GXYLT2 glucoside xylosyltransferase 2 2 2
MIRT487640 BRSK2 BR serine/threonine kinase 2 2 4
MIRT487755 SKI SKI proto-oncogene 2 4
MIRT489944 CPLX1 complexin 1 2 2
MIRT491101 MSI1 musashi RNA binding protein 1 2 4
MIRT491181 LAMA5 laminin subunit alpha 5 2 2
MIRT492355 SEMA7A semaphorin 7A (John Milton Hagen blood group) 2 2
MIRT493918 FAM127B retrotransposon Gag like 8A 2 4
MIRT493932 FAM127A retrotransposon Gag like 8C 2 4
MIRT494679 ARID3A AT-rich interaction domain 3A 2 2
MIRT494814 AKAP11 A-kinase anchoring protein 11 2 2
MIRT494835 ADCY9 adenylate cyclase 9 2 2
MIRT495455 PNMAL2 paraneoplastic Ma antigen family member 8B 2 2
MIRT496962 MAP1LC3B microtubule associated protein 1 light chain 3 beta 2 2
MIRT526228 MTRNR2L5 MT-RNR2-like 5 2 2
MIRT531028 TDGF1P3 teratocarcinoma-derived growth factor 1 pseudogene 3 2 2
MIRT557110 HOXA3 homeobox A3 2 2
MIRT560514 POGK pogo transposable element derived with KRAB domain 2 2
MIRT567753 DLC1 DLC1 Rho GTPase activating protein 2 2
MIRT569608 TRIM29 tripartite motif containing 29 2 2
MIRT570242 CPNE5 copine 5 2 2
MIRT572327 HSPB6 heat shock protein family B (small) member 6 2 2
MIRT572373 ATOX1 antioxidant 1 copper chaperone 2 2
MIRT575024 Tecpr2 tectonin beta-propeller repeat containing 2 2 5
MIRT576146 Hmox1 heme oxygenase 1 2 2
MIRT612443 SMOC2 SPARC related modular calcium binding 2 2 2
MIRT615404 VDAC2 voltage dependent anion channel 2 2 2
MIRT629114 CYCS cytochrome c, somatic 2 2
MIRT631362 FOXI2 forkhead box I2 2 2
MIRT639322 THBD thrombomodulin 2 2
MIRT643797 ABCC12 ATP binding cassette subfamily C member 12 2 2
MIRT669687 ABLIM1 actin binding LIM protein 1 2 2
MIRT670595 LLGL1 LLGL1, scribble cell polarity complex component 2 4
MIRT691190 NIF3L1 NGG1 interacting factor 3 like 1 2 2
MIRT691688 FLOT2 flotillin 2 2 2
MIRT697127 OTUD5 OTU deubiquitinase 5 2 2
MIRT700814 PHLDA2 pleckstrin homology like domain family A member 2 2 2
MIRT701248 NUP35 nucleoporin 35 2 2
MIRT702362 KLHL15 kelch like family member 15 2 2
MIRT703325 GDPD5 glycerophosphodiester phosphodiesterase domain containing 5 2 2
MIRT706060 PKD1 polycystin 1, transient receptor potential channel interacting 2 2
MIRT710475 CDH5 cadherin 5 2 2
MIRT713018 SLC4A2 solute carrier family 4 member 2 2 2
MIRT716427 RAB15 RAB15, member RAS oncogene family 2 2
MIRT718093 ABHD12 abhydrolase domain containing 12 2 2
MIRT718542 PIGQ phosphatidylinositol glycan anchor biosynthesis class Q 2 2
MIRT719122 CACFD1 calcium channel flower domain containing 1 2 2
MIRT721393 LDLRAD4 low density lipoprotein receptor class A domain containing 4 2 2
MIRT736283 CDC42 cell division cycle 42 2 0
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-6132 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-6132 Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-6132 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-6132 Cisplatin 5460033 NSC119875 approved resistant High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-6132 Temozolomide 5394 NSC362856 approved sensitive cell line (U251)
hsa-miR-6132 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-6132 Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-miR-6132 Osimertinib 71496458 NSC779217 approved resistant cell line (H1975)
hsa-miR-6132 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)

Error report submission